Cargando…

Mechanisms Underlying Cancer Growth and Apoptosis by DEK Overexpression in Colorectal Cancer

Our previous study indicated that DEK protein was overexpressed in colorectal carcinoma (CRC) compared with the normal colorectal mucosa. DEK was also significantly correlated with the prognostic characteristics of patients with CRC, demonstrating that DEK played an important role in CRC progression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Lijuan, Piao, Junjie, Ma, Yibing, Jin, Tiefeng, Quan, Chengshi, Kong, Jienan, Li, Yulin, Lin, Zhenhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207817/ https://www.ncbi.nlm.nih.gov/pubmed/25340858 http://dx.doi.org/10.1371/journal.pone.0111260

Ejemplares similares

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer
por: Lin, Lijuan, et al.
Publicado: (2013)

High expression of DEK predicts poor prognosis of gastric adenocarcinoma
por: Piao, Junjie, et al.
Publicado: (2014)

NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix
por: Ma, Yue, et al.
Publicado: (2014)

High expression of ezrin predicts poor prognosis in uterine cervical cancer
por: Kong, Jienan, et al.
Publicado: (2013)

Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
por: Jin, Jingchun, et al.
Publicado: (2012)

DEK promoted EMT and angiogenesis through regulating PI3K/AKT/mTOR pathway in triple-negative breast cancer
por: Yang, Yang, et al.
Publicado: (2017)

Ezrin promotes breast cancer progression by modulating AKT signals
por: Li, Nan, et al.
Publicado: (2019)

Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition
por: Kong, Jienan, et al.
Publicado: (2016)

The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival()
por: Hacker, Kari E, et al.
Publicado: (2018)

Ezrin promotes pancreatic cancer cell proliferation and invasion through activating the Akt/mTOR pathway and inducing YAP translocation
por: Quan, Chunji, et al.
Publicado: (2019)

Overexpression of the human DEK oncogene reprograms cellular metabolism and promotes glycolysis
por: Matrka, Marie C., et al.
Publicado: (2017)

DEK overexpression is predictive of poor prognosis in esophageal squamous cell carcinoma
por: Yi, Huochun, et al.
Publicado: (2019)

DEK is highly expressed in breast cancer and is associated with malignant phenotype and progression
por: Yang, Mai-Qing, et al.
Publicado: (2021)

Superior efficacy of co-treatment with the dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A against NSCLC
por: Piao, Junjie, et al.
Publicado: (2016)

Dissecting the Potential Interplay of DEK Functions in Inflammation and Cancer
por: Pease, Nicholas A., et al.
Publicado: (2015)

Potential of DEK proto-oncogene as a prognostic biomarker for colorectal cancer: An evidence-based review
por: Habiburrahman, Muhammad, et al.
Publicado: (2022)

Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence
por: Matrka, Marie C., et al.
Publicado: (2018)

Doxorubicin induces prolonged DNA damage signal in cells overexpressing DEK isoform-2
por: Özçelik, Emrah, et al.
Publicado: (2022)

HBXIP overexpression is correlated with the clinical features and survival outcome of ovarian cancer
por: Wang, Yixuan, et al.
Publicado: (2017)

Gigantol inhibits cell proliferation and induces apoptosis by regulating DEK in non-small cell lung cancer
por: Cai, Yuxing, et al.
Publicado: (2021)

Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer
por: Lin, Dong, et al.
Publicado: (2014)

PI3K/mTOR dual inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A synergistically exert anti-tumor activity in breast cancer
por: Chen, Liyan, et al.
Publicado: (2017)

DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer
por: Martinez-Useros, Javier, et al.
Publicado: (2014)

Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer
por: Datta, Antara, et al.
Publicado: (2011)

The role of DEK protein in hepatocellular carcinoma for progression and prognosis
por: Lin, Li-juan, et al.
Publicado: (2013)

Expression of DEK in pancreatic cancer and its correlation with clinicopathological features and prognosis
por: Zhao, Ting, et al.
Publicado: (2019)

DEK modulates both expression and alternative splicing of cancer-related genes
por: Liu, Bin, et al.
Publicado: (2022)

DEK Is a Potential Biomarker Associated with Malignant Phenotype in Gastric Cancer Tissues and Plasma
por: Lee, Kam-Fai, et al.
Publicado: (2019)

Prognostic role of DEK in human solid tumors: a meta-analysis
por: Liu, Gang, et al.
Publicado: (2017)

The SAF-box domain of chromatin protein DEK
por: Böhm, Friederike, et al.
Publicado: (2005)

The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer
por: Privette Vinnedge, Lisa M., et al.
Publicado: (2012)

DEK promotes HPV positive and negative head and neck cancer cell proliferation
por: Adams, Allie K., et al.
Publicado: (2014)

A DEK domain-containing protein GhDEK2D mediated Gossypium hirsutum enhanced resistance to Verticillium dahliae
por: Zhou, Jinglong, et al.
Publicado: (2022)

DEK Expression in Breast Cancer Cells Leads to the Alternative Activation of Tumor Associated Macrophages
por: Pease, Nicholas A., et al.
Publicado: (2020)

Super-resolution microscopy reveals the nanoscale cluster architecture of the DEK protein cancer biomarker
por: Pierzynska-Mach, Agnieszka, et al.
Publicado: (2023)

DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis
por: Mor-Vaknin, Nirit, et al.
Publicado: (2017)

DEK is required for homologous recombination repair of DNA breaks
por: Smith, Eric A., et al.
Publicado: (2017)

Role of the DEK oncogene in the development of squamous cell carcinoma
por: Ishida, Kazuhisa, et al.
Publicado: (2020)

Overexpression of CCDC34 in colorectal cancer and its involvement in tumor growth, apoptosis and invasion
por: Geng, Wei, et al.
Publicado: (2018)

Overexpression of DHX32 contributes to the growth and metastasis of colorectal cancer
por: Lin, Huayue, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ake7fc8jm5o78s1kr5rgigm70o